Abstract
We sought to confirm the identity of the tachykinin receptor subtype that mediates plasma extravasation in the rat trachea, and assess the respective contributions of neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE) in regulating this tachykinin-induced response. To achieve these aims, we determined the relative potencies of several natural tachykinins and receptor-selective synthetic agonists, both before and after inhibiting NEP with phosphoramidon and ACE with captopril. We also determined the effects of these peptidase inhibitors, and the NK-1 receptor antagonist L-703,606, on the plasma extravasation produced by capsaicin, which releases tachykinins endogenously from sensory nerve endings. We found that the rank order of potency for producing plasma extravasation in the rat trachea was NK-1 receptor agonist ([Sar9, Met(O2)11] SP)>substance P>neurokinin A> neurokinin B. The NK-2 ([Nle10]NKA (4–10)) and NK-3 ([MePhe7]NKB) receptor agonists were without effect. We observed no change in the relative potencies of these peptides after giving rats phosphoramidon or captopril, which suggests that the different peptide potencies are not simply the consequence of different rates of enzymatic degradation. Nevertheless, the responses to substance P and neurokinin A were clearly potentiated in rats given phosphoramidon, indicating that NEP effectively degrades tachykininsin vivo. No significant potentiation was evident for any peptide in rats given captopril. Similarly, the plasma extravasation produced by capsaicin was potentiated in rats given phosphoramidon, but not in those given captopril. Pretreating rats with L-703,606 abolished the response to capsaicin. We conclude from these observations that NK-1 receptors mediate tachykinin-induced plasma extravasation in the rat trachea, and that NEP regulates this response with little or no contribution from ACE.
Similar content being viewed by others
References
J. E. Maggio,Tachykinins, Ann. Rev. Neurosci.11, 13–28 (1988).
P. J. Barnes, J. N. Baraniuk and M. G. Belvisi,Neuropeptides in the respiratory tract. Am. Rev. Respir. Dis.144, 1187–1198, 1391–1399 (1991).
D. M. McDonald,The ultrastructure and permeability of tracheobronchial blood vessels in health and disease. Eur. Respir J.3, 572s-585s (1990).
K. Sertl, C. J. Wiedermann, M. L. Kowalski, S. Hurtado J. Plutchok, I. Linnoila, C. B. Pert and M. A. Kaliner,Substance P: The relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am. Rev. Respir. Dis.138, 151–159 (1988).
N. Frossard and C. Advenier,Tachykinin receptors and the airways. life Sci.49, 1941–1953 (1991).
D. F. Rogers, M. G. Belvisi, B. Aursudkij, T. W. Evans and P. J. Barnes,Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea-pigs. Br. J. Pharmacol.95, 1109–1116 (1988).
L. Abelli, C.A. Maggi, P. Rovero, E. Del Bianco, D. Regoli, G. Drapeau and A. Giachetti,Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: Evidence for the involvement of NK-1 receptors. J. Auton. Pharmacol.11, 267–275 (1991).
A. Eglezos, S. Giuliani, G. Viti and C. A. Maggi,Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK 1 receptors. Eur. J. Pharmacol.209, 277–279 (1991).
Y.-H. Lei, P. J. Barnes and D. F. Rogers,Inhibition of neurogenic plasma exudation in guinea-pig airways by CP-96, 345, a new non-peptide NK 1 receptor antagonist. Br. J. Pharmacol.105, 261–262 (1992).
C. Tousignant, C.-C. Chan, D. Guevremont, C. Brideau, J. J. Hale, M. MacCoss and I. W. Rodger,NK 2 receptors mediate plasma extravasation in guinea-pig lower airways. Br. J. Pharmacol.108, 383–386 (1993).
C. M. Lilly, J. M. Drazen and S. A. Shore,Peptidase modulation of airway effects of neuropeptides. Proc. Soc. Exp. Biol. Med.203, 388–404 (1993).
K. Sekizawa, J. Tamaoki, P. D. Graf, C. B. Basbaum, D. B. Borson and J. A. Nadel,Enkephalinase inhibitor potentiates mammalian tachykinin-induced contraction in ferret trachea, J. Pharmacol. Exp. Ther.243, 1211–1217 (1987).
A. R. Johnson, J. Ashton, W. W. Schulz and E. G. Erdös,Neutral metalloendopeptidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis.132, 564–568 (1985).
E. Umeno, J. A. Nadel, H.-T. Huang and D. M. McDonald,Inhibition of neutral endopeptidase potentiates neurogenic inflammation in the rat trachea. J. Appl. Physiol.66, 2647–2652 (1989).
G. Piedimonte, D. M. McDonald and J. A. Nadel,Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea, J. Clin. Invest.88, 40–44 (1991).
J. O. Lötvall, W. Elwood, K. Tokuyama, P. J. Barnes and K. F. Chung,Differential effects of phosphoramidon on neurokinin A- and substance P-induced airflow obstruction and airway microvascular leakage in guinea-pig. Br. J. Pharmacol.104, 945–949 (1991).
J. O. Lötvall, K. Tokuyama, C.-G. Löfdahl, A. Ullman, P. J. Barnes and K. F. Chung,Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage. J. Appl. Physiol.70, 2730–2735 (1991).
A. Saria, C.-R. Martling, Z. Yan, E. Theodorsson-Norheim, R. Gamse and J. M. Lundberg,Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am. Rev. Respir. Dis.137, 1330–1335 (1988).
A. Saria and J. M. Lundberg,Evans blue fluorescence: Quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods8, 41–49 (1983).
D. Regoli, G. Drapeau, S. Dion and R. Couture,New selective agonists for neurokinin receptors: Pharmacological tools for receptor characterization. Trends Pharmacol. Sci.9, 290–295 (1988).
T. M. Fong, R.-R. C. Huang and C. D. Strader,Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem.267, 25664–25667 (1992).
J. H. Zar,Blostatistical Analysis, 2nd ed., pp. 185–205, Prentice-Hall, Englewood Cliffs, NJ 1984.
L. Jacques, R. Couture, G. Drapeau and D. Regoli,Capillary permeability induced by intravenous neurokinins: Receptor characterization and mechanism of action. Naunyn-Schmiedeberg's Arch. Pharmacol.340, 170–179 (1989).
L. Abelli, V. Somma, C. A. Maggi, D. Regoli, M. Astolfi, M. Parlani, P. Rovero, B. Conte and A. Meli,Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: Evidence for the involvement of NK-1 receptors. J. Auton. Pharmacol.9, 253–263 (1989).
F. Y. Lam and W. R. Ferrell,Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br. J. Pharmacol.103, 1263–1267 (1991).
N. M. Hooper, A. J. Kenny and A. J. Turner,The metabolism of neuropeptides: Neurokinin A (substance K) is a substrate for endopeptidase-24.11 but not for peptidyl dipeptidase A (angiotensin-converting enzyme). Biochem. J.231, 357–361 (1985).
W. R. Welches, K. B. Brosnihan and C. M. Ferrario,A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci.52, 1461–1480 (1993).
J. J. Brokaw and G. W. White,Calcitonin gene-related peptide potentiates substance P-induced plasma extravasation in the rat trachea. Lung170, 85–93 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brokaw, J.J., White, G.W. Differential effects of phosphoramidon and captopril on NK1 receptor-mediated plasma extravasation in the rat trachea. Agents and Actions 42, 34–39 (1994). https://doi.org/10.1007/BF02014297
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02014297